We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Steerable Microcatheter Platform a Game-Changer in Endovascular Medicine

By HospiMedica International staff writers
Posted on 19 Apr 2022
Print article
Image: Giant basilar tip aneurysm access, PCA vessels coming out of aneurysm sac, using the Bendit21 (Photo courtesy of BENDIT Technologies)
Image: Giant basilar tip aneurysm access, PCA vessels coming out of aneurysm sac, using the Bendit21 (Photo courtesy of BENDIT Technologies)

A microcatheter platform with advanced steering and torqueability maneuvering capabilities enables navigation with or without guidewires, more precisely, and accurately, through all vasculatures, and potentially expanding indications, enhancing safety and saving procedure time.

The Bendit21 Steerable Microcatheter for treatment in the neuro, peripheral, and coronary vasculature from BENDIT Technologies (Tel Aviv, Israel) is equipped with a steerable distal tip, controlled by a 'steering slider' on the proximal steering handle. Endovascular specialists can bi-directionally rotate the tip by simply turning the torque knob on the steering handle. The company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bendit21 microcatheter for treatment in the neuro, peripheral, and coronary vasculature several months after the successful first use of the Bendit21 neuro catheter in the US in two life-saving procedures.

"We already have FDA clearance for the peripheral indication. Now that we have received 510K clearance for the Bendit21, with expanded indications for neuro, coronary and peripheral, endovascular specialists can begin utilizing the full potential of our steerable microcatheters," said Yossi Mazel, BENDIT CEO. "We are planning a commercial release in the coming months in select medical institutions in the United States."

"The Bendit technology presents a transformative paradigm in endovascular navigation that will revolutionize the way we access the vasculature, and will improve treatments throughout the arterial and venous systems, especially in the brain," added Professor Alejandro Berenstein, MD, a Clinical Professor of Neurosurgery, Radiology and Pediatrics, and Director of the Pediatric Cerebrovascular Program at the Mount Sinai Health System in New York and board member at BENDIT.

Related Links:
BENDIT Technologies 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Hydrogen Peroxide Sterilizer
HMA-30

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.